Found: 13
Select item for more details and to access through your institution.
ZYBT1, a potent, irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer.
- Published in:
- Pharmacology Research & Perspectives, 2020, v. 8, n. 4, p. 1, doi. 10.1002/prp2.565
- By:
- Publication type:
- Article
ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Synthesis and Anticonvulsant Activity of 3-(6-Substituted-benzothiazol-2-yl)-6-phenyl-[1, 3]-xazinane-2-thiones.
- Published in:
- Archiv der Pharmazie, 2002, v. 335, n. 8, p. 381, doi. 10.1002/1521-4184(200211)335:8<381::AID-ARDP381>3.0.CO;2-S
- By:
- Publication type:
- Article
Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2018, v. 96, n. 6, p. 587, doi. 10.1139/cjpp-2017-0683
- By:
- Publication type:
- Article
Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intake.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2016, v. 94, n. 2, p. 161, doi. 10.1139/cjpp-2014-0457
- By:
- Publication type:
- Article
Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2014, v. 92, n. 12, p. 975, doi. 10.1139/cjpp-2014-0310
- By:
- Publication type:
- Article
Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2013, v. 91, n. 12, p. 1009, doi. 10.1139/cjpp-2013-0189
- By:
- Publication type:
- Article
Sensitive and specific LC-ESI-MS/MS method for determination of ZYDPLA1, a novel long-acting dipeptidyl peptidase 4 inhibitor in rat plasma: An application for toxicokinetic study in rats.
- Published in:
- Biomedical Chromatography, 2017, v. 31, n. 11, p. n/a, doi. 10.1002/bmc.3984
- By:
- Publication type:
- Article
Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors.
- Published in:
- ChemMedChem, 2011, v. 6, n. 6, p. 1011, doi. 10.1002/cmdc.201100077
- By:
- Publication type:
- Article
Evaluation of Cardioprotective Effect of 3,5,3'-Tri-iodo-L-thyronine in Isoproterenol-Induced Cardiotoxicity.
- Published in:
- International Journal of Endocrinology, 2011, p. 1, doi. 10.1155/2011/908367
- By:
- Publication type:
- Article
Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitor 一种新型的长效二肽基肽酶-4抑制剂ZYDPLA1的药理特性
- Published in:
- Journal of Diabetes, 2015, v. 7, n. 5, p. 708, doi. 10.1111/1753-0407.12233
- By:
- Publication type:
- Article
Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (奥美拉唑改善唾液素-4 对 db/db小鼠的减肥与降糖作用)* Omeprazole improves the anti-obesity and antidiabetic effects of exendin-4 in db/db mice (奥美拉唑改善唾液素-4 对 db/db小鼠的减肥与降糖作用)
- Published in:
- Journal of Diabetes, 2013, v. 5, n. 2, p. 163, doi. 10.1111/j.1753-0407.2012.00227.x
- By:
- Publication type:
- Article
Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
- Published in:
- Journal of Diabetes, 2012, v. 4, n. 4, p. 369, doi. 10.1111/j.1753-0407.2012.00193.x
- By:
- Publication type:
- Article